News Briefs
✦ Prime Therapeutics LLC, the PBM co-owned by 18 Blue Cross and Blue Shield plans, hired a new data analytics executive team. The new hires include Urvi Randhar as senior vice president and chief information and t...
News Briefs
✦ The White House Office of Management and Budget (OMB) at press time had concluded its review of HHS’s controversial “rebate rule” that would effectively eliminate pharmaceutical manufacturer rebates in Me...
News Briefs
✦ Pfizer Inc. and BioNTech SE’s coronavirus vaccine candidate has demonstrated 90% efficacy against COVID-19 in patients that have not had the disease, according to company researchers. The announcement was met ...
News Briefs
✦ Oklahoma last month released a request-for-proposals from qualified insurers interested in participating in the state’s first managed Medicaid program. Beginning on Oct. 1, 2021, managed care organizations w...
News Briefs
✦ CMS is delaying the start of the Radiation Oncology Model from Jan. 1, 2021, to July 1, 2021. The move comes after CMS announced the launch date on Sept. 18, and multiple entities, including the American Society...
News Briefs
✦ HHS and the Dept. of Defense reached a deal with CVS Health Corp. and Walgreen Co. to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) nationwide, with no out-of-pocket c...
News Briefs
✦ Despite care utilization patterns rising closer to normal levels in the third quarter of 2020, adjusted earnings per share (EPS) for UnitedHealth Group fell 10% year-over-year to $3.51 as the company undertook ...
News Briefs
✦ Manufacturer prices for insulin in the United States were “considerably” — often five or 10 times — higher than those in other Organisation for Economic Co-operation and Development countries, according ...
News Briefs
✦ Molina Healthcare, Inc. on Sept. 29 said it entered into a definitive agreement to acquire substantially all of the assets of New York Medicaid managed care organization Affinity Health Plan for approximately $...
News Briefs
✦ Teva Pharmaceuticals USA, Inc. launched the first generics of Gilead Sciences, Inc.’s Truvada (emtricitabine/tenofovir disoproxil fumarate) and Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate). ...